Virtual Frontiers Lecture: Dr. Robert C. Green

10/02/2020 12:00 PM - 01:00 PM
Center for BrainHealthUT Dallas 

Event Pass Information

Event Pass Type
Frontiers Lecture

Event Details



The Center for BrainHealth invites top scientists in the field to share their knowledge with students, researchers and all who are interested in the science of brain health. The lectures focus on their latest approaches and findings. They are free when you register.

The Path to Preventive Genomics

Robert C. Green, MD, MPH

How are advances in genomics enhancing brain health and overall human health?

Hear about the exciting new findings in genomics that are revolutionizing medical care across multiple disciplines, preventing illness and extending healthy lifespan. 

Dr. Green is a physician-scientist and Professor of Medicine (Genetics) at Harvard Medical School who directs the Genomes2People Research Program at Brigham and Women’s Hospital and the Broad Institute.

Dr. Green is an internationally recognized leader in conducting research and developing policies to accelerate the implementation of genomic and precision medicine. He led the first experimental trials disclosing genetic risk for common complex disease and the first prospective studies to evaluate outcomes in direct-to-consumer genetic testing services. His work established the safety and feasibility of disclosing genetic risk information, assessed the impact of whole genome sequencing in primary care, created the concept of aggregate penetrance of genomic variants in a prospective population cohort and demonstrated the clinical utility and cost-effectiveness of genomic sequencing in healthy adults (the MedSeq Project), newborns (the BabySeq Project) and the active duty military (the MilSeq Project).

Dr. Green recently established the Brigham Preventive Genomics Clinic in Boston, and co-founded a tech-enabled telegenomics specialty practice, Genome Medical, that is now operating in all 50 US states. He is leading policy development for returning genomic information to research participants within the Global Alliance for Genomics and Health, the Verily-Google Baseline Project and US Precision Medicine Initiative.